Acrivon Therapeutics Inc. Common Stock (ACRV)
Company Info
| ISIN | US0048901096 |
|---|---|
| Sector | Healthcare |
| Industry | Biotechnology |
Highlights
| Market Cap | $270.78M |
|---|---|
| EPS | -$2.74 |
| EBITDA (TTM) | -$66.57M |
| Year Range | $3.19 - $14.30 |
| Target Price | $22.13 |
| Short % | 9.27% |
| Short Ratio | 0.53 |
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Popular comparisons: ACRV vs. VTGN
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Acrivon Therapeutics Inc. Common Stock, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Acrivon Therapeutics Inc. Common Stock had a return of 69.92% year-to-date (YTD) and -40.67% in the last 12 months.
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | 69.92% | 10.00% |
| 1 month | -16.32% | 2.41% |
| 6 months | 64.57% | 16.70% |
| 1 year | -40.67% | 26.85% |
| 5 years (annualized) | N/A | 12.81% |
| 10 years (annualized) | N/A | 10.84% |
Monthly Returns
The table below presents the monthly returns of ACRV, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | -25.81% | 33.15% | 47.12% | 27.13% | 69.92% | ||||||||
| 2023 | 40.63% | 25.43% | -37.55% | -2.99% | -4.31% | 10.02% | -4.01% | -5.79% | -18.43% | -45.19% | -22.71% | 21.48% | -57.29% |
| 2022 | -22.78% | -10.35% | -30.77% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of ACRV is 29, suggesting that the investment has average results relative to other stocks in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.
ACRV (Acrivon Therapeutics Inc. Common Stock)
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Acrivon Therapeutics Inc. Common Stock (ACRV) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the Acrivon Therapeutics Inc. Common Stock. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Acrivon Therapeutics Inc. Common Stock was 85.34%, occurring on Feb 14, 2024. The portfolio has not yet recovered.
The current Acrivon Therapeutics Inc. Common Stock drawdown is 63.97%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -85.34% | Feb 15, 2023 | 251 | Feb 14, 2024 | — | — | — |
| -32.24% | Nov 17, 2022 | 28 | Dec 28, 2022 | 24 | Feb 2, 2023 | 52 |
| -2.62% | Feb 9, 2023 | 2 | Feb 10, 2023 | 1 | Feb 13, 2023 | 3 |
Volatility
Volatility Chart
The current Acrivon Therapeutics Inc. Common Stock volatility is 35.03%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Income Statement
| TTM | |
|---|---|
| Revenue | |
Total Revenue | 0.00 |
Cost Of Revenue | 0.00 |
Gross Profit | 0.00 |
| Operating Expenses | |
Selling, General & Admin Expenses | 0.00 |
R&D Expenses | 0.00 |
Total Operating Expenses | 0.00 |
| Income | |
Income Before Tax | 0.00 |
Operating Income | 0.00 |
EBIT | 0.00 |
Earnings From Continuing Operations | 0.00 |
Net Income | 0.00 |
Income Tax Expense | 0.00 |
Interest Expense | 0.00 |
Other Non-Operating Income (Expenses) | 0.00 |
Extraordinary Items | 0.00 |
Discontinued Operations | 0.00 |
Effect Of Accounting Charges | 0.00 |
Non Recurring | 0.00 |
Minority Interest | 0.00 |
Other Items | 0.00 |